Home Cart 0 Sign in  
X

[ CAS No. 85230-37-1 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 85230-37-1
Chemical Structure| 85230-37-1
Chemical Structure| 85230-37-1
Structure of 85230-37-1 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 85230-37-1 ]

Related Doc. of [ 85230-37-1 ]

Alternatived Products of [ 85230-37-1 ]

Product Details of [ 85230-37-1 ]

CAS No. :85230-37-1 MDL No. :MFCD09263987
Formula : C6H8N2O3 Boiling Point : -
Linear Structure Formula :- InChI Key :FGCPAXRNQIOISG-UHFFFAOYSA-N
M.W : 156.14 Pubchem ID :12847993
Synonyms :

Calculated chemistry of [ 85230-37-1 ]

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 5
Fraction Csp3 : 0.33
Num. rotatable bonds : 3
Num. H-bond acceptors : 4.0
Num. H-bond donors : 2.0
Molar Refractivity : 36.7
TPSA : 75.21 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.72 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.01
Log Po/w (XLOGP3) : 0.75
Log Po/w (WLOGP) : 0.29
Log Po/w (MLOGP) : -0.18
Log Po/w (SILICOS-IT) : 0.63
Consensus Log Po/w : 0.5

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.42
Solubility : 5.95 mg/ml ; 0.0381 mol/l
Class : Very soluble
Log S (Ali) : -1.91
Solubility : 1.93 mg/ml ; 0.0123 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -1.13
Solubility : 11.7 mg/ml ; 0.0746 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.22

Safety of [ 85230-37-1 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 85230-37-1 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 85230-37-1 ]
  • Downstream synthetic route of [ 85230-37-1 ]

[ 85230-37-1 ] Synthesis Path-Upstream   1~5

  • 1
  • [ 40876-98-0 ]
  • [ 85230-37-1 ]
YieldReaction ConditionsOperation in experiment
77%
Stage #1: With acetic acid In toluene at 20℃; for 0.5 h;
Stage #2: With hydrazine hydrochloride In toluene at 100℃;
Acetic acid (150 mL) was added drop-wise to a solution of sodium 1 ,4-diethoxy- (0282) 1 ,4-dioxobut-2-en-2-olate (30.0 g, 0.143 mol) in toluene (150 mL), and the mixture was stirred at room temperature for 30 minutes, whereupon hydrazine monohydrochloride (85percent, 17 g, 0.29 mol) was added. The reaction mixture was stirred for an additional 30 minutes at room temperature and subsequently heated at 100 °C overnight. It was then concentrated in vacuo and extracted with ethyl acetate (500 mL); the organic layer was washed sequentially with saturated aqueous sodium bicarbonate solution (200 mL) and saturated aqueous sodium chloride solution (200 mL), dried over sodium sulfate, filtered, and concentrated under reduced pressure to provide the product as a yellow solid. Yield: 17 g, 0.1 1 mol, 77percent. 1H NMR (400 MHz, DMSO-cf6) δ 12.75 (br s, 1 H), 5.91 (br s, 1 H), 4.24 (q, J=7 Hz, 2H), 1 .27 (t, J=7 Hz, 3H).
Reference: [1] Patent: WO2017/145013, 2017, A1, . Location in patent: Page/Page column 54
[2] Chemical and Pharmaceutical Bulletin, 1983, vol. 31, # 4, p. 1228 - 1234
  • 2
  • [ 2644-70-4 ]
  • [ 88330-76-1 ]
  • [ 85230-37-1 ]
YieldReaction ConditionsOperation in experiment
92%
Stage #1: for 0.333333 h;
Stage #2: for 0.5 h;
Stage #3: at 100℃; for 24.5 h; Heating / reflux
Diethyloxalacetate, sodium salt (14. 53 g, 69. 15 mmol) was dissolved in 100 mL of benzene and stirred for 20 min. To the solution was added 100 ML of acetic acid and the reaction mixture was stirred for a further 30 min. Hydrazine monohydrochloride (9. 47 g, 138 mmol) was added and the reaction mixture was stirred for an additional 30 min. The reaction was brought to reflux at 100 C for 24 h. The reaction was then removed from heat and cooled to room temperature and extracted with ethyl acetate and washed with 10percent hydrochloric acid, saturated sodium bicarbonate solution, water and then brine. The solvent was removed IN VACUO TO yield an oily solid which was then triturated with a 2 : 1 mixture of diethyl ether : hexanes to yield 3 (10. 00 g, 92percent) as an off-white solid : LRMS (electrospray) ; m/z [M+H1+ = 157.
Reference: [1] Patent: WO2004/74257, 2004, A1, . Location in patent: Page 26; 37; 38
  • 3
  • [ 64-17-5 ]
  • [ 687-00-3 ]
  • [ 85230-37-1 ]
Reference: [1] Synthesis, 2003, # 15, p. 2353 - 2357
  • 4
  • [ 64-17-5 ]
  • [ 3702-98-5 ]
  • [ 85230-37-1 ]
Reference: [1] Synthesis, 2003, # 15, p. 2353 - 2357
  • 5
  • [ 85230-37-1 ]
  • [ 109-64-8 ]
  • [ 153597-59-2 ]
YieldReaction ConditionsOperation in experiment
68% With potassium carbonate In acetonitrile for 16 h; Heating / reflux Step 1: Preparation of ethyl 6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2- carboxylate :; To the stirred suspension of ethyl 5-hydroxy-1H-pyrazole-3-carboxylate (10.34 g, 0.66 mol) and 36.62 g of potassium carbonate in 500 mi of acetonitrile was added 14.7 g of 1,3-dibromopropane, and refluxed for 16 hours. The reaction mixture was allowed to cool to room temperature, then filtered, the solid was washed with acetonitrile. The filtrate was concentrated to an oil. The residue was dissolved in ethyl acetate and extracted with water. The organic phase was dried over MgS04 and evaporated to dryness. 8.80 g of the desired product was obtained (68percent), m. p. 44-46°C (M+H) + 197. 1.
68% With potassium carbonate In acetonitrile for 16 h; Heating / reflux To the stirred suspension of ethyl 5-hydroxy-1H-pyrazole-3-carboxylate (10.34 g, 0.66 mol) and 36.62 g of potassium carbonate in 500 ml of acetonitrile was added 14.7 g of 1,3-dibromopropane, and refluxed for 16 hours. The reaction mixture was allowed to cool to room temperature, then filtered, the solid was washed with acetonitrile. The filtrate was concentrated to an oil. The residue was dissolved in ethyl acetate and extracted with water. The organic phase was dried over MgSO4 and evaporated to dryness. 8.80 g of the desired product was obtained (68percent), m.p. 44-46° C. (M+H)+197.1.
61% With potassium carbonate In acetonitrile for 16 h; Reflux Potassium carbonate (48.3 g, 349 mmol) was added to a solution of C1 (13.65 g, 87.42 mmol) in acetonitrile (250 mL). The mixture was stirred at room temperature for 15 minutes, whereupon 1 ,3-dibromopropane (10 mL, 98 mmol) was added drop-wise, and the reaction mixture was heated at reflux for 16 hours. It was then allowed to cool to room temperature and filtered; t e filtered solids were washed with acetonitrile (2 x 100 mL). The filtrate was concentrated in vacuo, and the residue was purified via chromatography on silica gel (Gradient: 50percent to 95percent ethyl acetate in heptane) to afford the product as an orange oil. Yield: 10.48 g, 53.4 mmol, 61 percent. LCMS m/z 197.0 [M+H]+. 1H NMR (400 MHz, CDCI3) δ 6.03 (s, 1 H), 4.39 (q, J=7.1 Hz, 2H), 4.34-4.30 (m, 2H), 4.26 (t, J=6.2 Hz, 2H), 2.33-2.26 (m, 2H), 1.39 (t, J=7.1 Hz, 3H).
Reference: [1] Journal of Medicinal Chemistry, 2006, vol. 49, # 15, p. 4623 - 4637
[2] Patent: WO2003/93279, 2003, A1, . Location in patent: Page/Page column 137
[3] Patent: US2006/276445, 2006, A1, . Location in patent: Page/Page column 42
[4] Patent: WO2017/145013, 2017, A1, . Location in patent: Page/Page column 54-55
[5] Journal of Heterocyclic Chemistry, 1993, vol. 30, # 4, p. 1097 - 1100
[6] Patent: US2004/132708, 2004, A1,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 85230-37-1 ]

Alcohols

Chemical Structure| 1018446-60-0

[ 1018446-60-0 ]

Methyl 5-hydroxy-1H-pyrazole-3-carboxylate

Similarity: 0.97

Chemical Structure| 51986-17-5

[ 51986-17-5 ]

Ethyl 5-hydroxy-1-methyl-1H-pyrazole-3-carboxylate

Similarity: 0.90

Chemical Structure| 89603-60-1

[ 89603-60-1 ]

5-Hydroxy-1H-pyrazole-3-carboxylic acid

Similarity: 0.89

Chemical Structure| 51985-95-6

[ 51985-95-6 ]

Methyl 5-hydroxy-1-methyl-1H-pyrazole-3-carboxylate

Similarity: 0.87

Chemical Structure| 58364-97-9

[ 58364-97-9 ]

5-Hydroxy-1-methyl-1H-pyrazole-3-carboxylic acid

Similarity: 0.79

Esters

Chemical Structure| 1018446-60-0

[ 1018446-60-0 ]

Methyl 5-hydroxy-1H-pyrazole-3-carboxylate

Similarity: 0.97

Chemical Structure| 51986-17-5

[ 51986-17-5 ]

Ethyl 5-hydroxy-1-methyl-1H-pyrazole-3-carboxylate

Similarity: 0.90

Chemical Structure| 5932-27-4

[ 5932-27-4 ]

Ethyl 1H-pyrazole-3-carboxylate

Similarity: 0.89

Chemical Structure| 51985-95-6

[ 51985-95-6 ]

Methyl 5-hydroxy-1-methyl-1H-pyrazole-3-carboxylate

Similarity: 0.87

Chemical Structure| 15366-34-4

[ 15366-34-4 ]

Methyl 1H-pyrazole-3-carboxylate

Similarity: 0.85

Related Parent Nucleus of
[ 85230-37-1 ]

Pyrazoles

Chemical Structure| 1018446-60-0

[ 1018446-60-0 ]

Methyl 5-hydroxy-1H-pyrazole-3-carboxylate

Similarity: 0.97

Chemical Structure| 51986-17-5

[ 51986-17-5 ]

Ethyl 5-hydroxy-1-methyl-1H-pyrazole-3-carboxylate

Similarity: 0.90

Chemical Structure| 89603-60-1

[ 89603-60-1 ]

5-Hydroxy-1H-pyrazole-3-carboxylic acid

Similarity: 0.89

Chemical Structure| 5932-27-4

[ 5932-27-4 ]

Ethyl 1H-pyrazole-3-carboxylate

Similarity: 0.89

Chemical Structure| 51985-95-6

[ 51985-95-6 ]

Methyl 5-hydroxy-1-methyl-1H-pyrazole-3-carboxylate

Similarity: 0.87